Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I A/B Study of the Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors

NCT01999738 is registered in ClinicalTrials.gov with Endocyte as lead sponsor.

NCT NCT01999738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01999738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I A/B Study of the Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors
Lead sponsor
Endocyte
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2013
Completion date
April 26, 2018
Enrollment
93 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung carcinoma, solid tumors